Ramosetron Pre-treatment for PONV and QT Prolongation
Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
Participant gender:
Summary
Ramosetron is commonly used to prevent postoperative nausea and vomiting (PONV) in the
Eastern Asia. The prolongation of QTc interval is a main side effect. In this study, the
pre-treatment time of ramosetron to decrease PONV, and QTc prolongation is compared.